Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Greenbaum

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Science Advances|December 4, 2024
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicityMelica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, et al.
Nature Cancer|October 23, 2023
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemiaKatherine Knorr, Jahan Rahman, Caroline Erickson, et al.
Immunity|January 21, 2016
Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus InfectionNicholas S Heaton, Natasha Moshkina, Romain Fenouil, et al.
Nature Structural & Molecular Biology|September 5, 2018
Influenza virus infection causes global RNAPII termination defectsNan Zhao, Vittorio Sebastiano, Natasha Moshkina, et al.
Immunity|June 8, 2020
Immunology of COVID-19: Current State of the ScienceNicolas Vabret, Graham J Britton, Conor Gruber, et al.
Cell|June 25, 2021
Pharmacologic modulation of RNA splicing enhances anti-tumor immunitySydney X Lu, Emma De Neef, James D Thomas, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancerWungki Park, Shigeaki Umeda, Marc Hilmi, et al.
Nature|January 15, 2025
IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancerMasataka Amisaki, Abderezak Zebboudj, Hiroshi Yano, et al.
European Urology|November 16, 2024
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial CarcinomaKwanghee Kim, Syed M Alam, Fengshen Kuo, et al.
Science Translational Medicine|June 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccineMathieu Gigoux, Morten O Holmström, Roberta Zappasodi, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Science Advances|December 4, 2024
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicityMelica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, et al.
Nature Cancer|October 23, 2023
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemiaKatherine Knorr, Jahan Rahman, Caroline Erickson, et al.
Immunity|January 21, 2016
Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus InfectionNicholas S Heaton, Natasha Moshkina, Romain Fenouil, et al.
Nature Structural & Molecular Biology|September 5, 2018
Influenza virus infection causes global RNAPII termination defectsNan Zhao, Vittorio Sebastiano, Natasha Moshkina, et al.
Immunity|June 8, 2020
Immunology of COVID-19: Current State of the ScienceNicolas Vabret, Graham J Britton, Conor Gruber, et al.
Cell|June 25, 2021
Pharmacologic modulation of RNA splicing enhances anti-tumor immunitySydney X Lu, Emma De Neef, James D Thomas, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancerWungki Park, Shigeaki Umeda, Marc Hilmi, et al.
Nature|January 15, 2025
IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancerMasataka Amisaki, Abderezak Zebboudj, Hiroshi Yano, et al.
European Urology|November 16, 2024
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial CarcinomaKwanghee Kim, Syed M Alam, Fengshen Kuo, et al.
Science Translational Medicine|June 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccineMathieu Gigoux, Morten O Holmström, Roberta Zappasodi, et al.
Pageof 4